|
1
|
Engblom C, Pfirschke C and Pittet MJ: The
role of myeloid cells in cancer therapies. Nat Rev Cancer.
16:447–462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
James BR, Brincks EL, Kucaba TA, Boon L
and Griffith TS: Effective TRAIL-based immunotherapy requires both
plasmacytoid and CD8α dendritic cells. Cancer Immunol Immunother.
63:685–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oppenheim JJ and Yang D: Alarmins:
Chemotactic activators of immune responses. Curr Opin Immunol.
17:359–365. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiba S, Baghdadi M, Akiba H, Yoshiyama H,
Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan
JD, et al: Tumor-infiltrating DCs suppress nucleic acid-mediated
innate immune responses through interactions between the receptor
TIM-3 and the alarmin HMGB1. Nat Immunol. 13:832–842. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scaffidi P, Misteli T and Bianchi ME:
Release of chromatin protein HMGB1 by necrotic cells triggers
inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang D, Kang R, Zeh HJ III and Lotze MT:
High-mobility group box 1 and cancer. Biochim Biophys Acta.
1799:131–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martinotti S, Patrone M and Ranzato E:
Emerging roles for HMGB1 protein in immunity, inflammation, and
cancer. Immunotargets Ther. 4:101–109. 2015.PubMed/NCBI
|
|
9
|
Tang D, Kang R, Livesey KM, Cheh CW,
Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ III
and Lotze MT: Endogenous HMGB1 regulates autophagy. J Cell Biol.
190:881–892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Campana L, Bosurgi L and Rovere-Querini P:
HMGB1: A two-headed signal regulating tumor progression and
immunity. Curr Opin Immunol. 20:518–523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ogata M, Hino S, Saito A, Morikawa K,
Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K,
et al: Autophagy is activated for cell survival after endoplasmic
reticulum stress. Mol Cell Biol. 26:9220–9231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoyer-Hansen M and Jäättelä M: Connecting
endoplasmic reticulum stress to autophagy by unfolded protein
response and calcium. Cell Death Differ. 14:1576–1582. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Capan E, Zhao Y, Zhao J, Stolz D,
Watkins SC, Jin S and Lu B: Autophagy is induced in CD4+ T cells
and important for the growth factor-withdrawal cell death. J
Immunol. 177:5163–5168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang R, Livesey KM, Zeh HJ, Loze MT and
Tang D: HMGB1: A novel Beclin 1-binding protein active in
autophagy. Autophagy. 6:1209–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lutz MB, Kukutsch N, Ogilvie AL, Rössner
S, Koch F, Romani N and Schuler G: An advanced culture method for
generating large quantities of highly pure dendritic cells from
mouse bone marrow. J Immunol Methods. 223:77–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khong HT and Restifo NP: Natural selection
of tumor variants in the generation of ‘tumor escape’ phenotypes.
Nat Immunol. 3:999–1005. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Steinman RM and Banchereau J: Taking
dendritic cells into medicine. Nature. 449:419–426. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Banchereau J and Palucka AK: Dendritic
cells as therapeutic vaccines against cancer. Nat Rev Immunol.
5:296–306. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim R, Emi M and Tanabe K: Cancer
immunoediting from immune surveillance to immune escape.
Immunology. 121:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu
Y, Xie M, Yin X, Livesey KM, Lotze MT, et al: HMGB1-induced
autophagy promotes chemotherapy resistance in leukemia cells.
Leukemia. 25:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang D and Lotze MT: Tumor immunity times
out: TIM-3 and HMGB1. Nat Immunol. 13:808–810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kusume A, Sasahira T, Luo Y, Isobe M,
Nakagawa N, Tatsumoto N, Fujii K, Ohmori H and Kuniyasu H:
Suppression of dendritic cells by HMGB1 is associated with lymph
node metastasis of human colon cancer. Pathobiology. 76:155–162.
2009. View Article : Google Scholar : PubMed/NCBI
|
